Key result
Atherosclerosis shows greater endothelial dysfunction on FMD than hypertension.
Why the study?
Flow-mediated dilation assesses endothelial function in hypertension and atherosclerosis, but the relative extent of impairment across these two conditions remains uncertain.
Is flow-mediated dilation (FMD) more impaired in adults with atherosclerosis compared to those with hypertension?
Meta-Analysis
Is flow-mediated dilation (FMD) more impaired in adults with atherosclerosis compared to those with hypertension?
Endothelial dysfunction, as measured by flow-mediated dilation, is significantly impaired in both hypertension and atherosclerosis, with a greater degree of impairment observed in atherosclerosis.
Answers are grounded in this paper and cite their sources.
Greater endothelial impairment in atherosclerosis than hypertension may inform risk stratification; leaves open whether this reflects causality or shared pathways.
Background: Flow-mediated dilation (FMD) is a key noninvasive method for assessing endothelial function, an important factor in both hypertension and atherosclerosis. However, the relative extent of impairment across these two conditions remains uncertain. Objectives: To compare endothelial-dependent vasodilation in adults with hypertension and atherosclerosis and to assess heterogeneity, reporting bias, and certainty of evidence. Methods: This paper used Preferred Reporting Items (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) 2020 as a guideline to conduct a systematic review and meta-analysis. The searches were conducted in PubMed, Embase, and the Cochrane Library until September 2025. Qualified studies were human based (participants aged ≥18 years), had reported FMD, and had sufficient data to be analyzed. The effect sizes were pooled using a random-effects model with the help of the R software (version 4.4.1) using metafor package. Results: Fourteen articles were found to have passed the inclusion criteria. Standardized mean differences (SMDs) that were pooled showed an impaired FMD in both conditions but more in atherosclerosis (SMD − 0.92, 95% confidence interval [CI] −1.07 to − 0.77) than in hypertension (SMD − 0.72, 95% CI − 0.83 to − 0.62). Heterogeneity was none ( I 2 = 0%) with hypertension and moderate ( I 2 = 55) with atherosclerosis, and there was low evidence of publication bias (Egger P > 0.1). Conclusion: Both hypertension and atherosclerosis are characterized by marked endothelial dysfunction, with a trend toward greater impairment in atherosclerosis. Future research should prioritize the standardization of FMD protocols to improve comparability across studies.
No takes yet. Share an insight, caveat, or question.
Madaniah Omar Zakari (2025) conducted a meta-analysis in Hypertension and atherosclerosis. Atherosclerosis vs. Hypertension was evaluated on Endothelial-dependent vasodilation assessed by flow-mediated dilation (FMD) (SMD -0.92 (atherosclerosis) vs SMD -0.72 (hypertension), 95% CI -1.07 to -0.77 (atherosclerosis); -0.83 to -0.62 (hypertension)). Flow-mediated dilation showed marked endothelial dysfunction in both conditions, with greater impairment in atherosclerosis than hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: